Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats

Diabetes

Volumn 60, Issue 5, 2011, Pages 1582-1589

  Chan, Owen ^a   Paranjape, Sachin ^a   Czyzyk, Daniel ^a   Horblitt, Adam ^a   Zhu, Wanling ^a   Ding, Yuyan ^a   Fan, Xiaoning ^a   Seashore, Margretta ^a   Sherwin, Robert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ADRENALIN; BICUCULLINE METHIODIDE; CATECHOLAMINE; GLUCAGON; GLUTAMATE DECARBOXYLASE 65; INSULIN; ISOPHANE INSULIN; STREPTOZOCIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; EXTRACELLULAR FLUID; GENE SILENCING; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL REGULATION; HORMONE RESPONSE; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOBLOTTING; INFUSION PUMP; INSULIN BLOOD LEVEL; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RNA SEQUENCE; TANDEM MASS SPECTROMETRY; ZONA INCERTA;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GAMMA-AMINOBUTYRIC ACID; GLUCOSE CLAMP TECHNIQUE; GLUTAMATE DECARBOXYLASE; HYPOGLYCEMIA; IMMUNOBLOTTING; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 79959410500     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1579     Document Type: Article

References (44)

1. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
2. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract 2008;14:750-756
3. Biggers DW, Myers SR, Neal D, et al. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 1989;38:7-16 (Pubitemid 19021810)
4. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997;99:361-365 (Pubitemid 27053991)
5. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994;93:1677-1682 (Pubitemid 24116408)
6. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995;44:180-184
7. Cryer PE. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus. Horm Metab Res 1997;29:92-96 (Pubitemid 27209909)
8. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005;54:3592-3601 (Pubitemid 43334356)
9. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182:171-173
10. Fukuda M, Tanaka A, Tahara Y, et al. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 1988;37:81-88 (Pubitemid 18036462)
11. Cooperberg BA, Cryer PE. Insulin reciprocally regulates glucagon secretion in humans. Diabetes 2010;59:2936-2940
12. Paranjape SA, Chan O, Zhu W, et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes 2010;59:1521-1527
13. Egefjord L, Petersen AB, Rungby J. Zinc, alpha cells and glucagon secretion. Curr Diabetes Rev 2010;6:52-57
14. Zhou H, Zhang T, Harmon JS, Bryan J, Robertson RP. Zinc, not insulin, regulates the rat a-cell response to hypoglycemia in vivo. Diabetes 2007;56:1107-1112 (Pubitemid 46525066)
15. Xu E, Kumar M, Zhang Y, et al. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006;3:47-58
16. Maher F, Simpson IA, Vannucci SJ. Alterations in brain glucose transporter proteins, GLUT1 and GLUT3, in streptozotocin diabetic rats. Adv Exp Med Biol 1993;331:9-12 (Pubitemid 23180882)
17. Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 1998;797:1-11 (Pubitemid 28331484)
18. McCall AL. The impact of diabetes on the CNS. Diabetes 1992;41:557-570
19. McCall AL. Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol 2004;490:147-158 (Pubitemid 38482168)
20. Mundinger TO, Mei Q, Figlewicz DP, Lernmark A, Taborsky GJ Jr. Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. Am J Physiol Endocrinol Metab 2003;285:E1047-E1054 (Pubitemid 37296326)
21. McCall AL, Sussman I, Tornheim K, Cordero R, Ruderman NB. Effects of hypoglycemia and diabetes on fuel metabolism by rat brain microvessels. Am J Physiol 1988;254:E272-E278
22. Ruderman NB, Ross PS, Berger M, Goodman MN. Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats. Biochem J 1974;138:1-10
23. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes 2006;55:929-934 (Pubitemid 44100166)
24. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 1995;95:2403-2408
25. Beverly JL, de Vries MG, Beverly MF, Arseneau LM. Norepinephrine mediates glucoprivic-induced increase in GABA in the ventromedial hypothalamus of rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R990-R996
26. Beverly JL, De Vries MG, Bouman SD, Arseneau LM. Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia. Am J Physiol Regul Integr Comp Physiol 2001;280:R563-R569
27. Chan O, Lawson M, Zhu W, Beverly JL, Sherwin RS. ATP-sensitive K(+) channels regulate the release of GABA in the ventromedial hypothalamus during hypoglycemia. Diabetes 2007;56:1120-1126 (Pubitemid 46525084)
28. Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes 2006;55:1080-1087 (Pubitemid 44100185)
29. Chan O, Cheng H, Herzog R, et al. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 2008;57:1363-1370
30. Hedrington MS, Farmerie S, Ertl AC, Wang Z, Tate DB, Davis SN. Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans. Diabetes 2010;59:1074-1081
31. Giordano R, Grottoli S, Brossa P, et al. Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf) 2003;59:314-320 (Pubitemid 37046984)
32. Van Vugt DA, Washburn DL, Farley AE, Reid RL. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam. Neuroendocrinology 1997;65:344-352 (Pubitemid 27174060)
33. Cheng H, Zhou L, Zhu W, et al. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation. Am J Physiol Endocrinol Metab 2007;293:E705-E712 (Pubitemid 47358982)
34. McDermott JC, Hutber A, Tan MH, Bonen A. The use of a cell-free perfusate in the perfused rat hindquarter: methodological concerns. Can J Physiol Pharmacol 1989;67:1450-1454 (Pubitemid 20031826)
35. McCrimmon RJ, Shaw M, Fan X, et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 2008;57:444-450
36. Bolteus AJ, Garganta C, Bordey A. Assays for measuring extracellular GABA levels and cell migration rate in acute slices. Brain Res Brain Res Protoc 2005;14:126-134 (Pubitemid 40249953)
37. Beverly JL, Martin RJ. Increased GABA shunt activity in VMN of three hyperphagic rat models. Am J Physiol 1989;256:R1225-R1231
38. Beverly JL, Oster MH, Castonguay TW, Stern JS. Dietary fat, hypothalamic glutamate decarboxylase, and food intake of streptozotocin-diabetic rats. Am J Physiol 1991;261:R1554-R1559
39. Ohtani N, Ohta M, Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 1997;69:1622-1628 (Pubitemid 27406963)
40. Angulo MC, Le Meur K, Kozlov AS, Charpak S, Audinat E. GABA, a forgotten gliotransmitter. Prog Neurobiol 2008;86:297-303
41. Lee M, Schwab C, McGeer PL. Astrocytes are GABAergic cells that modulate microglial activity. Glia 2011;59:152-165
42. Zhu W, Czyzyk D, Paranjape SA, et al. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab 2010;298:E971-E977
43. Kawamori D, Kurpad AJ, Hu J, et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 2009;9:350-361
44. Fan X, Ding Y, Brown S, et al. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes. Am J Physiol Regul Integr Comp Physiol 2009;296:R1702-R1708